Acura Pharma Revenue, Profits - ACUR Quarterly Income Statement

Add to My Stocks
$0.4 $0 (0%) ACUR stock closing price Jun 20, 2018 (Closing)

Financial analysis of Acura Pharma involves more than just checking the Acura Pharma stock price, by looking at the financial statements of the company in detail. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. The income statement for ACUR which shows a YOY revenue decline of 0 is specific to a period of time. Investors typically check YoY or QoQ revenue growth. Revenue for year 2017 Q4 is $- and has decreased from $- quarter on quarter as is evident when you compare the latest figures in the latest Acura Pharma profit and loss statement with those of the prior corresponding period. Also see Acura Pharma assets and Acura Pharma free cash flow for a complete valuation of ACUR stock.

View and download details of revenue and profits for Acura Pharma for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Acura Pharma Revenues or Net Sales
Cost Of Goods Sold (COGS)---------
Acura Pharma Gross Profit
Research & Development Expense-1.07M1.02M---1.4M1.01M-
Selling General & Admin Expense-1.06M1.06M1.29M1.14M1.33M1.83M2.24M2.59M
Income Before Depreciation Depletion Amortization-1.75M-2.06M-1.99M-1.71M-2.06M-3.07M-3.13M-0.72M
Depreciation Depletion Amortization---------
Non Operating Income---------
Interest Expense---------
Acura Pharma Pretax Income
Provision for Income Taxes-0.13M--------
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations-1.74M-2.2M-2.15M-1.53M-2.25M-3.29M-3.38M-0.92M
Extraordinary Items & Discontinued Operations---------
Acura Pharma Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS21M16.69M11.97M12.08M11.9M11.88M11.86M11.97M11.84M
Average Shares used to compute Basic EPS21M16.69M11.97M11.91M11.9M11.88M11.86M11.97M11.84M
Income Before Nonrecurring Items-1.74M-2.2M-2.15M-1.53M-2.25M-3.29M-3.38M-0.92M
Income from Nonrecurring Items---------
Acura Pharma Earnings Per Share Basic Net
Acura Pharma Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.08-0.12-
Preferred Dividends Acc Pd---------
Dividends Common0.00--------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Before investing one should read a report on Acura Pharma stock analysis. It helps to look at the following income statement items:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that ACUR stock has a topline or revenue of $- for 2017 Q4 as per this Acura Pharma revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-1.74M for Acura Pharma for 2017 Q4. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the ACUR income statement, one can check the Acura Pharma historical stock prices to check how the price has moved with time.

Acura Pharma Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Dividend Yield